NCT04300231View on ClinicalTrials.gov

Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 22, 2019

Primary Completion Date

December 23, 2021

Study Completion Date

December 24, 2021

Conditions
Cystectomy
Interventions
DRUG

epidural bupivacaine 0.05%

Mix of epidural bupivacaine 0.05% and hydromorphone 0.05mg/ml will be given using PCEA.

DRUG

Liposomal bupivacaine

20 ml

DRUG

bupivacaine 0.125%

40 mL

DRUG

bupivacaine 0.5%

60 mL

DRUG

/hydromorphone 0.05mg/ml

Mix of epidural bupivacaine 0.05% and hydromorphone 0.05mg/ml will be given using PCEA.

DRUG

injectable saline

40 mL

Trial Locations (1)

46202

Indiana Univeristy, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT04300231 - Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy | Biotech Hunter | Biotech Hunter